Navigation Links
Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
Date:4/9/2008

IRVINE, Calif., April 9, 2008 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, was awarded a three-year contract with MedAssets Supply Chain Systems. MedAssets Supply Chain Systems provides group purchasing and supply chain services in the U.S., serving more than 125 health systems, including 2,500 hospitals.

Under the terms of the agreement, MedAssets will co-market Alsius' IVTM systems and catheters via its sales force, and the two companies will collaborate on customized marketing promotions to MedAssets' customers. Alsius will be the exclusive provider of intravascular temperature management products to MedAssets' extensive network of acute care hospitals.

"This agreement represents yet another endorsement of our technology by one of the elite hospital partners in the U.S.," said Bill Worthen, president and chief executive officer of Alsius. "We were happy to work with MedAssets during the selection process to demonstrate the importance of effective control of body temperature in critically ill patients, and how our 'inside-out' approach can do so precisely and efficiently."

Prior to its agreement with MedAssets Supply Chain Systems, Alsius underwent MedAssets' rigorous nine-step contract selection process, including thorough review by its research team and the MedAssets Contracting Advisory Team, to determine whether Alsius' products meet the needs of its hospital customers.

"MedAssets prides itself on offering customized solutions to its hospital customers, which is why their input plays an important role in the contracts we award," said Mark Miriani, president, MedAssets Supply Chain
'/>"/>

SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alsius Corporation to Host Third Quarter 2007 Financial Results Conference Call/Webcast on November 13, 2007
2. Alsius Corporation Announces Program for Early Exercise of Warrants
3. Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
4. Alsius Corporation Receives Regulatory Approval in China and Mexico
5. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
6. Brooke Franchise Corporation Announces Selected July Results
7. MedThink Communications Retained by NanoBio Corporation
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
10. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
11. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, 2014 ... West Africa is starting to spread faster than ever, the World ... the deadly viral infection were reported in just one week. ... with roughly half of those reported in the past three weeks, ... tops 2,600. WHO has estimated that as many as 20,000 ...
(Date:9/18/2014)... It’s been just a few short weeks ... bunion splint to website visitors, but already the response has ... absolutely delighted. It is perfect and I find it sooo ... THANK YOU FOR LISTENING!!!" Another user compared the original ... used to slip to the end of my toe. Now ...
(Date:9/18/2014)... It is that time of year – time ... again, Evensong Spa at Heidel House Resort ... at a special $50 rate Oct. 20 through Nov. 1. ... & Resorts , is the only Wisconsin destination spa participating ... health and wellness by experiencing affordable spa and wellness treatments. ...
(Date:9/18/2014)... supplements of selenium or vitamin E don,t seem ... men, a new study indicates. Previous animal research ... cataracts. To investigate this further, William Christen, from Brigham ... and his colleagues examined data from a randomized, placebo-controlled ... initially designed to study prevention of prostate cancer. ...
(Date:9/18/2014)... 19, 2014 In 2003, ... Mission (Misión Barrio Adentro), which it hoped ... system (see Section 6.1.3.). In 2009, it ... Autonomous Service of Pharmaceutical Elaborations (Servicio Autónomo ... provides medicines at a cheaper rate than ...
Breaking Medicine News(10 mins):Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:Evensong Spa Celebrates Spa Week with $50 Services 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 3Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4
... By Randy Dotinga HealthDay Reporter , TUESDAY, Sept. ... gel based on the active ingredient of the injectable Botox ... known as crow,s feet -- without the pain of needles. ... toxin, last for about four months, comparable to that produced ...
... HealthDay Reporter , TUESDAY, Sept. 20 (HealthDay News) -- Young adults ... birth much thought, but a new study finds that health problems ... some time. From 18 to 36 years of age, people ... death compared to young adults born at a normal gestational age, ...
... Reporter , TUESDAY, Sept. 20 (HealthDay News) -- Adding ... and teens with obsessive-compulsive disorder, new research shows. ... the Journal of the American Medical Association , ... obsessive-compulsive disorder (OCD). "[If] a child has ...
... against methamphetamine and nicotine have been selected to receive ... The two scientists, Dr. Thomas Kosten, of Baylor ... the University of Connecticut, Storrs, will each receive $500,000 ... according to the National Institute on Drug Abuse (NIDA), ...
... 20 (HealthDay News) -- New research finds that compared to ... diagnosis and boosted the likelihood that high-risk, underserved women who ... But there,s a big catch. Researchers were able to reduce ... -- compared to the usual $3,500 -- thanks to a ...
... of Health (NIH) has awarded nearly $2 million to ... University to develop a new class of therapeutics for ... five-year project focuses on developing biomaterials capable of capturing ... to wound sites to enhance tissue regeneration in adults. ...
Cached Medicine News:Health News:Anti-Wrinkle Gel Might Work Like Botox Without Needles 2Health News:Anti-Wrinkle Gel Might Work Like Botox Without Needles 3Health News:Problems From Preterm Birth May Return in Adulthood 2Health News:Problems From Preterm Birth May Return in Adulthood 3Health News:Adding Psychotherapy to Meds Helps Kids With OCD 2Health News:NIDA Avant-Garde-Medications Development Award winners announced 2Health News:MRI Can Spot Breast Cancer in High-Risk Women: Study 2Health News:Transformative NIH grant will support development of tissue regeneration therapeutics 2Health News:Transformative NIH grant will support development of tissue regeneration therapeutics 3
(Date:9/18/2014)... 2014  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of RNA viruses, today announced a research collaboration ... animal testing of the Company,s lead compound, SB ... Pathogens," against which currently there are no effective ... Bank,s proprietary Small Molecule Nucleic Acid Hybrid ...
(Date:9/18/2014)... 18, 2014 /CNW/ - A new expert panel report, ... , released today by the Council of Canadian ... medicines for children. Each year about half of ... least one prescription drug. Much of this prescribing is ... use), creating potential health risks. Children have ...
(Date:9/18/2014)... , Sept. 18, 2014   Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced the first presentation ... AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of Collagenase Optimizing ... study evaluated collagenase clostridium histolyticum (CCH) for the ... same hand. In addition, the study examined expanded ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
... Incorporated,s (Nasdaq: VPHM ) first quarter financial results ... 28, 2011 before the open of the U.S. financial markets. ... live audio webcast at 9:00 a.m. Eastern Time on the ... the 2011 first quarter financial results and other business. ...
... LLC, through its website lawsuitssettlementfunding.com announced today ... in need of lawsuit cash advances ... leader; however they are striving to set themselves apart ... that they have ramped up their operations involving Avandia ...
Cached Medicine Technology:ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011 2Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2
Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Medicine Products: